Investors in It

Downing Ventures, we are integral to the UK venture capital landscape, focusing on nurturing early-stage technology companies with significant growth potential. Specializing in sectors like technology, healthcare, fintech, and renewable energy, our firm provides vital seed and Series A funding to innovative UK-based businesses. As part of Downing LLP, our extensive experience and network allow us to actively support our portfolio companies beyond mere financial backing. Our approach emphasizes impactful investments that not only promise financial returns but also contribute positively to society and the environment. By partnering closely with entrepreneurs, we aim to propel emerging startups towards market leadership, facilitating their journey through strategic guidance and operational assistance.

FORWARD.one is a European venture capital firm specializing in investing in hardware innovations across sectors such as Semiconductors, Climate Tech, and High Tech. Founded with a focus on supporting entrepreneurs who are passionate about solving complex challenges through innovative technologies, FORWARD.one seeks to identify and nurture groundbreaking solutions. The firm is dedicated to partnering with early-stage companies, providing not just capital but also strategic guidance and operational support to help them scale and succeed. Committed to making a positive impact, FORWARD.one aims to build a portfolio of companies that drive innovation in their respective fields and contribute to a more sustainable and technologically advanced world.

Boundary Capital Partners LLP is a venture capital firm specializing in early-stage growth companies, primarily within the technology sector. By offering both financial investment and hands-on support, Boundary Capital Partners helps innovative tech startups achieve their growth potential. Their investment approach combines capital with strategic guidance, leveraging their expertise and network to drive business success. Committed to fostering technological advancement, Boundary Capital Partners partners with visionary entrepreneurs to build the next generation of market-leading companies.

Par Equity is a prominent early-stage venture capital firm specializing in investing in innovative, high-growth technology companies. With a focus on supporting entrepreneurs and driving innovation, Par Equity provides strategic capital and operational guidance to help startups scale and achieve their potential. Their investment approach emphasizes collaboration and long-term partnership, aiming to create sustainable value for both entrepreneurs and investors. Par Equity's portfolio spans diverse sectors within the technology industry, reflecting their commitment to fostering groundbreaking technologies and market-leading businesses.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.

PROfounders Capital is an early-stage venture capital firm backed by successful entrepreneurs, dedicated to investing in technology startups across Europe. With a deep understanding of entrepreneurial challenges and opportunities, PROfounders Capital provides strategic capital and operational support to innovative early-stage companies. Their investment approach emphasizes partnering with ambitious founders to accelerate growth and build market-leading businesses. PROfounders Capital's extensive network and sector expertise enable them to identify and support promising startups, driving innovation and fostering entrepreneurial success throughout Europe.

Sapphire Capital Partners specializes in facilitating tax-efficient schemes aimed at fostering the growth of companies and alternative investment funds. With a focus on leveraging tax incentives to fuel business expansion, Sapphire Capital Partners provides strategic advisory services and investment solutions tailored to optimize financial outcomes. Their expertise lies in structuring and managing innovative investment vehicles that support both entrepreneurial ventures and institutional investors. By navigating regulatory landscapes and maximizing fiscal benefits, Sapphire Capital Partners enables businesses to achieve their growth objectives effectively and sustainably.

Bayes Entrepreneurship Fund is a £15 million venture capital fund targeting early-stage, high-growth businesses in the UK. We prioritize entrepreneurs from all backgrounds, not just graduates of Bayes Business School (formerly Cass), who show revenue traction and have received initial concept-stage or seed funding. Initial investments range from £250,000 to £1,000,000, tailored to each company's stage and financial needs. While we primarily focus on B2B enterprises, we have successfully supported management teams in the B2C sector as well. As an active investor, we can lead funding rounds or participate alongside other investors. We also reserve funds for follow-on investments as our portfolio companies grow. With a diverse investment approach spanning multiple sectors, we seek UK-based companies with innovative business models and strong growth potential.

Lough Shore Investments is a venture capital firm specializing in financing startups located in Northern Ireland and Ireland. With a focus on supporting early-stage companies, Lough Shore Investments provides capital and strategic guidance to foster growth and innovation. The firm aims to identify promising entrepreneurial ventures and contribute to their development through targeted investment and operational support. Lough Shore Investments plays a crucial role in the local startup ecosystem by facilitating access to funding and resources essential for startup success.

Craigie Capital is dedicated to building, accelerating, and investing in early-stage technology startups. Based on their proactive approach, Craigie Capital provides strategic support and funding to entrepreneurs aiming to disrupt their respective industries. The firm's focus lies in identifying innovative solutions with the potential for significant market impact. By leveraging their experience and network, Craigie Capital aims to propel the growth and success of startups, fostering their journey from inception to scalability.

Anthemis is a forward-thinking asset management platform dedicated to transforming finance for a better world. With a focus on innovation and sustainability, Anthemis seeks to reinvent finance through strategic investments in disruptive technologies and ventures. By leveraging their expertise and network, Anthemis supports and scales businesses that have the potential to reshape the financial industry. Committed to driving positive change, Anthemis aims to foster innovation, create value, and contribute to a more inclusive and sustainable financial ecosystem globally.

NCL Technology Ventures specializes in healthcare investments, recognizing the modernization of healthcare as a significant growth driver in the 21st century. As a dedicated healthcare investor, NCL identifies and supports companies pioneering transformational changes in the sector. They provide transformational equity capital and strategic expertise to companies leveraging innovation and technology to advance healthcare solutions. NCL's mission is to foster companies that innovate in preventing, treating, and curing various medical conditions, thereby addressing future health challenges and creating valuable businesses. By navigating the dynamic healthcare landscape, NCL Technology Ventures aims to achieve clinical and commercial success for its portfolio companies.